| Literature DB >> 24031868 |
Fernando Rosado Spilki1, Ana Cláudia Franco, Paulo Michel Roehe.
Abstract
Specific IgM, IgA, IgG1, IgG2, as well as neutralizing antibody responses were evaluated in sera of calves experimentally infected with two isolates of bovine herpesvirus type 1 (BoHV1) of distinct subtypes (subtype 1, BoHV1.1; subtype 2a, BoHV-1.2a). No significant differences were observed in the antibody responses induced by each BoHV-1 subtype. The antibody responses following primary acute infection were characterized by an increase in specific IgM and IgA levels between days 2 and 14 post inoculation (pi). IgG1 was detected from days 11 to 30 pi. IgG2 was detected on the sample taken on day 30 pi. Reactivation of infection following dexamethasone administration induced a significant rise in IgA levels, whereas IgG1 and IgG2 levels, which were at high levels from the beginning of the reactivation process, showed a slight alteration after corticosteroid treatment. These results suggest that it is possible to estimate the dynamics of BoHV-1 infections with basis on the analysis of class- and subclass-specific antibody responses. Such information may be particularly useful for the study of the kinetics of the infection in a herd and to aid in the adoption of appropriate control measures..Entities:
Keywords: ELISA; bovine herpesvirus type 1; immunoglobulin subclasses; infectious bovine rhinotracheitis
Year: 2012 PMID: 24031868 PMCID: PMC3768835 DOI: 10.1590/S1517-83822012000200021
Source DB: PubMed Journal: Braz J Microbiol ISSN: 1517-8382 Impact factor: 2.476
Figure 1Serum neutralizing antibody responses in calves infected with bovine herpesvirus 1.1 (BoHV-1.1) (full squares) or BoHV1.2 (full triangles) and control uninfected calves (empty squares)following primary infection (a)and reactivation (b). Neutralizing antibody titres expressed as the reciprocal of the geometric mean of the neutralizing antibodies for each group.
Figure 2Specific IgM antibody levels in sera of calves experimentally infected with BoHV-1.1 or BoHV1.2a. Data measured by ELISA and expressed as mean percentual optical densities (%OD; see text for methods) for each group of calves. Plot a: at primary acute infection; b: t reactivation. Full squares: BoHV-1.1 infected calves; full triangles: BHV-1.2a infected calves. Empty squares: control uninfected calves.
Figure 3ELISA analysis of IgA specific antibody in sera of calves experimentally infected with BoHV-1.1 or BoHV1.2a. Data measured by ELISA and expressed as mean percentual optical densities (%OD; see text for methods) for each group of calves. Plot a: at primary acute infection; b: t reactivation. Full squares: BoHV-1.1 infected calves; full triangles: BHV-1.2a infected calves. Empty squares: control uninfected calves.
Figure 4ELISA analysis of IgG1 specific antibody in sera of calves experimentally infected with BoHV-1.1 or BoHV1.2a. Data measured by ELISA and expressed as mean percentual optical densities (%OD; see text for methods) for each group of calves. Plot a: at primary acute infection; b: t reactivation. Full squares: BoHV-1.1 infected calves; full triangles: BHV-1.2a infected calves. Empty squares: control uninfected calves.
Figure 5ELISA analysis of IgG2 specific antibody responses in sera of calves experimentally infected with BoHV-1.1 or BoHV1.2a. Data measured by ELISA and expressed as mean percentual optical densities (%OD; see text for methods) for each group of calves. Plot a: at primary acute infection; b: t reactivation. Full squares: BoHV-1.1 infected calves; full triangles: BHV-1.2a infected calves. Empty squares: control uninfected calves.Data measured by ELISA
Estimate of the status of infection with basis on the patterns of isotype and subclass specific anti-bovine herpesvirus 1.1 (BHV-1.1) or 1.2a (BHV-1.2a) antibodies.
| Status of infection | Isotype-specific profile |
|---|---|
| Uninfected cattle | IgM- IgA- IgG1- IgG2- SNAa- |
| Up to day 15 post-infection | IgM+ IgA+ IgG1- IgG2- SNA-or+ |
| Between days 15 and 30 post- infection | IgM+ IgA+ IgG1+ IgG2+ SNA+ |
| During latency (after day 30 post infection) | IgM- IgA- IgG1+ IgG2+ SNA+ |
| After reactivation | IgM- IgA+ IgG1+ IgG2+ SNA+ |
+ = present ; - = absent ; a = serum neutralizing antibodies